Health Benefits of Expressive Writing: Study One

Completed · Not applicable

Conditions studied: Breast Cancer, Breast Neoplasm

In brief

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

Key facts

Study ID

NCT03546673

Run by

University of Houston

People needed

96

Starts

2009-07-01

Expected to finish

2011-10-01

Last updated by the study team

2019-09-04

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 1) having a breast cancer diagnosis
• 2) completing primary medical treatment within four years
• 3) being comfortable writing and speaking Chinese (i.e. Mandarin or Cantonese)

Where it is running

• Herald Cancer Association — Los Angeles, California, United States
• University of Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.